Search

everythinglearnresearchcommunity

for

Search:↓

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

A new method efficiently creates biaryl N-oxides with potential for cancer treatment and drug development.

New compounds may help treat prostate issues without affecting androgen receptors.

New drug uses show promise but need more research.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

The document explains how to make a compound called 3.BETA.-Benzoyloxy-4-pregnen-16.ALPHA.,17.ALPHA.-epoxy-6,20-dione and describes its crystal structure.

The compound 4c showed strong potential as an anticancer agent.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.

A3B5 can reduce skin pigmentation and slow melanoma growth.

GD-23 reduces anxiety by relying on neurosteroid production.

A new compound that could treat various androgen-related conditions was created and analyzed.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

N13-substituted evodiamine derivatives improved anticancer activity and solubility, showing promise for drug development.

Scientists improved an enzyme to better produce a hair growth-promoting chemical from an immunosuppressant.

New progesterone-based compounds can block male hormones.

Scientists made two new chemicals that might help treat diseases caused by male hormones.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

The salts have diverse molecular packing with significant hydrogen interactions.